Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-10

Clinical Trial Update: A Study of the Safety and Effectiveness of Levofloxacin Compared to Ticarcillin/Clavulanate Alone or Followed by Amoxicillin/Clavulanate in the Treatment of Complicated Skin Infections [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and effectiveness of levofloxacin compared with ticarcillin/clavulanate (used alone or after amoxicillin/clavulanate) for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)
  • Ticarcillin/Clavulanate (Ticarcillin/clavulanate)
  • amoxicillin-clavulanate (amoxicillin-clavulanate)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Skin Diseases, Bacterial | Phase 3 | Status: COMPLETED